VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BIOX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BIOXBioceres Crop Solutions Corp.
$0.23$15M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBIOXQuarterly Financials

Bioceres Crop Solutions Corp. (BIOX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Bioceres Crop Solutions Corp. (BIOX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

BIOX Income Statement

Quarterly statement

BIOX Income Statement

Bioceres Crop Solutions Corp. (BIOX) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22
Sales/Revenue57M38.2M73.67M77.44M74.37M59.6M98.88M92.62M124.31M84M140.3M116.18M105.07M92.98M94.55M126.84M101.56M68.23M92.31M66.35M
Revenue Growth %-23.35%-35.9%-25.49%-16.39%-40.18%-29.05%-29.52%-20.28%18.31%-9.66%48.39%-8.4%3.46%36.28%2.42%91.16%25.3%92%92.31%57.59%
Cost of Goods Sold43.2M26.7M47.36M41.79M51.02M36.12M57.56M55.38M82.7M41.4M88.8M72.65M66.37M36.63M60.79M75.41M65.13M44.57M54.98M37.33M
COGS % of Revenue75.79%69.9%64.29%53.97%68.61%60.61%58.21%59.79%66.52%49.29%63.29%62.53%63.16%39.39%64.29%59.45%64.13%65.32%59.56%56.26%
Gross Profit13.8M11.5M26.31M35.64M23.35M23.47M41.32M37.24M41.62M42.6M51.5M43.53M38.7M56.36M33.76M51.43M36.42M23.66M37.33M29.02M
Gross Margin %24.21%30.1%35.71%46.03%31.39%39.39%41.79%40.21%33.48%50.71%36.71%37.47%36.84%60.61%35.71%40.55%35.87%34.68%40.44%43.74%
Gross Profit Growth %-40.89%-51.01%-36.33%-4.29%-43.9%-44.9%-19.76%-14.45%7.53%-24.41%52.55%-15.36%6.26%138.19%-9.56%77.2%11.54%54.45%57.75%50.83%
Operating Expenses23.9M18M18.49M27.88M30.26M22.54M26.13M33.58M31.73M29.28M34.7M39.39M32.21M26.87M31.58M35.12M26.69M21.31M20.77M18.56M
OpEx % of Revenue41.93%47.12%25.09%36.01%40.69%37.82%26.43%36.25%25.52%34.86%24.73%33.91%30.65%28.89%33.4%27.69%26.29%31.23%22.5%27.98%
Selling, General & Admin23.9M012.63M16.54M22.66M21.01M17.5M21.13M22.58M30.7M31.16M26.75M2.63M23.99M28.41M24.95M19.03M18.03M18.81M12.5M
SG&A % of Revenue41.93%-17.14%21.37%30.47%35.26%17.7%22.81%18.17%36.55%22.21%23.03%2.5%25.8%30.05%19.67%18.74%26.43%20.38%18.84%
Research & Development002.35M5.72M2.65M3.66M1.97M4.41M5.37M3.59M3.64M4.58M4.14M3.89M3.46M3.85M2.3M1.84M1.38M1.43M
R&D % of Revenue--3.19%7.38%3.56%6.14%1.99%4.76%4.32%4.27%2.6%3.94%3.94%4.19%3.66%3.04%2.26%2.69%1.5%2.16%
Other Operating Expenses01000K1000K1000K1000K-1000K1000K1000K1000K-1000K-108.01K-1000K-159.06K-22.1K-330.54K1000K-163.34K1000K-570.29K1000K
Operating Income-10.1M-6.5M7.82M7.76M-6.92M933.21K15.19M3.66M9.48M13.2M16.8M5.29M5.11M29.87M2.22M16.99M9.98M2.15M17.7M10.04M
Operating Margin %-17.72%-17.02%10.62%10.02%-9.3%1.57%15.36%3.96%7.63%15.72%11.97%4.56%4.86%32.12%2.35%13.4%9.83%3.15%19.18%15.13%
Operating Income Growth %-46.03%-796.52%-48.5%111.84%-172.93%-92.93%-9.57%-30.8%85.75%-55.8%657.11%-68.84%-48.85%1290.8%-87.46%69.25%-27.18%-55.02%53.5%19.94%
EBITDA-10.1M-3.1M9.01M13.59M-2.01M11.67M16.42M8.98M16.09M18.14M21.71M10.12M9.52M34.85M7.67M21.53M13.5M4.27M19.39M11.9M
EBITDA Margin %-17.72%-8.12%12.23%17.55%-2.7%19.58%16.6%9.69%12.95%21.6%15.48%8.71%9.06%37.48%8.12%16.97%13.29%6.26%21%17.93%
EBITDA Growth %-403.1%-126.56%-45.12%51.45%-112.47%-35.67%-24.39%-11.33%69.05%-47.94%183.01%-52.98%-29.48%716.04%-60.42%80.92%-14.21%-34.77%51.02%24.89%
D&A (Non-Cash Add-back)03.4M1.19M5.83M4.91M10.74M1.22M5.31M6.61M4.94M4.91M4.83M4.41M4.99M5.45M4.54M3.52M2.12M1.69M1.86M
EBIT-10.1M-6.5M5.65M3.18M-37.79M559.23K12.58M-1.41M2.47M15.15M14.8M4.78M1.46M29.49M-1.98M14.64M7.75M2.91M17.7M7.41M
Net Interest Income-20.3M-6.6M-7.02M-8.55M-7.13M-6.11M-5.28M-6.06M-7.21M-4.38M-7.27M-7.03M-5.76M-7.58M-9.96M-6.78M-4.9M-4.78M-8.22M-3.34M
Interest Income00000000020.66K29.95K000000000
Interest Expense20.3M6.6M7.02M8.55M7.13M6.11M5.28M6.06M7.21M4.4M7.3M7.03M5.76M4.48M9.96M6.78M4.9M4.78M8.22M3.34M
Other Income/Expense-19.9M-11M-9.19M-13.13M-38M-6.53M-7.89M-11.13M-15.59M-4.38M-7.26M-7.54M-9.47M-7.58M-9.96M-8.07M-7.62M-4.78M-8.22M-5.18M
Pretax Income-30M-17.5M-1.37M-5.37M-44.92M-5.6M7.3M-7.46M-6.11M8.82M9.54M-2.25M-4.37M22.29M-7.74M8.92M2.36M-2.64M9.48M4.86M
Pretax Margin %-52.63%-45.81%-1.85%-6.93%-60.4%-9.39%7.38%-8.06%-4.91%10.5%6.8%-1.94%-4.16%23.97%-8.19%7.04%2.32%-3.86%10.27%7.33%
Income Tax1.8M-4M3.11M2.08M6.75M-4.01M636.15K-1.27M-4.03M-955.83K8.3M429.04K-1.58M-5.19M684.91K5.01M6.9M4.34M4.14M2.6M
Effective Tax Rate %-6%22.86%-227.6%-38.82%-15.02%71.57%8.71%16.97%65.94%-10.84%87.02%-19.07%36.11%-23.28%-8.85%56.17%292.17%-164.6%43.68%53.4%
Net Income-27.5M-12.3M-183.04M-7.33M-47.89M-1.3M143.53K-6.37M-1.53M9.26M108.45K-4.59M-1.71M28.2M-8.16M498.3K-5.01M-6.49M3.43M874.14K
Net Margin %-48.25%-32.2%-248.44%-9.46%-64.39%-2.19%0.15%-6.88%-1.23%11.02%0.08%-3.95%-1.63%30.33%-8.63%0.39%-4.94%-9.51%3.71%1.32%
Net Income Growth %42.57%-843.31%--15.05%-3028.44%-114.09%32.35%-38.71%10.36%-67.17%101.33%-1021.47%65.95%534.73%-338.01%-43%-891.26%-449.5%428.71%112.54%
Net Income (Continuing)-31.8M-13.5M-4.48M-7.45M-51.66M-1.59M6.66M-6.2M-2.08M9.78M1.24M-2.68M-2.79M27.48M-8.43M3.91M-4.54M-6.98M5.34M2.49M
Discontinued Operations1000K0-1000K000-1000K0000000000000
Minority Interest25M27.9M32.85M29.66M32.41M36.26M36.52M36.29M35.3M35.17M34.7M33.66M31.65M33.18M33.97M34.29M30.68M28.75M27.25M24.09M
EPS (Diluted)-0.39-0.19-2.88-0.12-0.70-0.020.00-0.09-0.030.140.00-0.07-0.030.45-0.130.01-0.11-0.160.080.02
EPS Growth %44.29%-817.87%--37.3%-2666.8%-114.79%--19.56%6.99%-68.89%101.31%-75.27%381.25%-260.89%-60.68%-602.28%-424.59%386.75%110.84%
EPS (Basic)-0.39-0.19-2.88-0.12-0.70-0.020.00-0.09-0.030.150.00-0.07-0.030.45-0.130.01-0.11-0.160.080.02
Diluted Shares Outstanding63.6M63.6M63.48M63.43M63.2M62.8M63.2M62.9M60.59M66.8M63.88M62.85M62.8M63.08M61.66M61.74M45.87M41.14M42.4M42.38M
Basic Shares Outstanding63.6M63.6M63.48M63.43M63.2M62.8M62.82M62.85M60.59M62.8M62.84M62.85M62.8M62M61.66M60.54M45.87M41.14M41.1M41.1M
Dividend Payout Ratio--------------------